The global herpes labialis treatment market is estimated to be valued at USD 1,238.7 million in 2025 and is projected to reach USD 1,887.1 million by 2035, registering a CAGR of 4.3% over the forecast ...

The global hematology diagnostics market is estimated to be valued at USD 3,971.8 million in 2025 and is projected to reach USD 6,287.2 million by 2035, registering a compound annual growth rate of 6.

The global Metagenomics Market is estimated to be valued at USD 231.1 million in 2025 and is projected to reach USD 442.07 million by 2035, registering a CAGR of 6.7% over the forecast period. The ...

Thursday, July 3, 2025: HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM: HCM; HKEX:13) will announce its interim results for the six months ended June 30, 2025 on Thursday, August 7, 2025 at 7:00 am ...

The global esophagoscopes & gastroscopes market is estimated to be valued at USD 1,376.9 million in 2025 and is projected to reach USD 2,350.9 million by 2035, registering a CAGR of 5.5% over the ...

AbbVie has announced a definitive agreement to acquire Capstan Therapeutics, a clinical-stage biotechnology company, for up ...

NHS introduces 'innovator passport' to streamline medical tech adoption, reducing bureaucracy and ensuring equitable patient ...

IntroductionIf you’re detail-oriented and enjoy working with scientific equipment, a career as a Lab Technician could be the ...

The announcement of a Life Science Strategy from the European Commission [2 July] includes action to address long-standing ...

CET/CESTRelease of an ad hoc announcement pursuant to Art. 53 LRThe issuer is solely responsible for the content of this announcement.PRESS RELEASE | AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR Evolva ...

BRUSSELS, BE / ACCESS Newswire / July 3, 2025 / Brussels transformed into a Champions League pitch for tobacco harm reduction as the World Vapers' Alliance (WVA) honoured Sweden, the Czech Republic, ...

VANCOUVER, BC / ACCESS Newswire / July 2, 2025 / Onco-Innovations Limited (CBOE CA:ONCO)(OTCQB:ONNVF)(Frankfurt:W1H,WKN:A3EKSZ) ("Onco" or the "Company") is pleased to announce that on July 2, 2025, ...